Howard Hughes Medical Institute’s Sandisk SNDK Stock Holding History

Howard Hughes Medical Institute’s Portfolio SNDK Stock Details SNDK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30	Closed	-$7.12K	–	501
2025 Q4	$7.12K	Buy	+30	New	+$6.01K	﹤0.01%	276

Other funds holding SNDK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Howard Hughes Medical Institute's SNDK Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Sandisk (SNDK) in Q1 2026, closing a stake of 30 shares — an estimated $7.12K sold.

Howard Hughes Medical Institute first reported a position in SNDK in Q4 2025 and held it in 1 quarter. The position peaked at $7.12K in Q4 2025. 1,179 funds tracked by Wall St. Rank hold SNDK as of Q1 2026.

Howard Hughes Medical Institute reported no remaining Sandisk position as of Q1 2026 after selling out during the quarter.
Howard Hughes Medical Institute sold 30 Sandisk shares in Q1 2026, an estimated $7.12K.
Howard Hughes Medical Institute first reported a position in Sandisk in Q4 2025 and held it in 1 quarter.
Howard Hughes Medical Institute's Sandisk position peaked at $7.12K in Q4 2025.
1,179 funds tracked by Wall St. Rank held Sandisk as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.